Teyi Pharmaceutical Group Co (SZSE:002728) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Teyi Pharmaceutical Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Teyi Pharmaceutical Group Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Teyi Pharmaceutical Group Co's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Teyi Pharmaceutical Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Teyi Pharmaceutical Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teyi Pharmaceutical Group Co LT-Debt-to-Total-Asset Chart

Teyi Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.14

0.12

0.14

Teyi Pharmaceutical Group Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Teyi Pharmaceutical Group Co LT-Debt-to-Total-Asset Calculation

Teyi Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	2512.637
	=	0.00

Teyi Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0	/	2491.27
	=	0.00

Teyi Pharmaceutical Group Co (SZSE:002728) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Teyi Pharmaceutical Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Teyi Pharmaceutical Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Teyi Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teyi Pharmaceutical Group Co Ltd (SZSE:002728) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 9, 11, Changxing Road, Taicheng, Guangdong Province, Taishan, CHN, 529200

Website

https://www.tczy.com.cn

Teyi Pharmaceutical Group Co Ltd is engaged in Research and development, production and sales of traditional Chinese medicines and chemical preparations.

Executives

Chen Xi Liang	Directors, Directors, and Executives
Zhang Yong Zhao	Executives
Xu Shao Hua	Securities Affairs Representative
Xu Wei Gao	Director
Xu Song Qing	Directors, executives
Liu Guang Tao	Executives
Du Yong Chun	Supervisors
Huang Yan Ling	Executives
Chen Guang Ting	Supervisors

Teyi Pharmaceutical Group Co Headlines

No Headlines